CaaMTech

📍 Issaquah, United States🗓 Founded 2019👥 9 employees💰 Last funded Jan 2021
Pharmaceutical Manufacturing🌐 caam.tech
Website LinkedIn
CaaMTech is a pharmaceutical drug discovery company utilizing a collaborative scientific approach to engineering novel small-molecule therapeutics. We are focused on creating and optimizing next-generation psychedelic-inspired medicines to treat mental health conditions. CaaMTech has carefully selected a diverse group of highly-skilled experts including scientists, healthcare professionals, and technologists at the forefront of their respective fields. Our team members have Ph.D., MBA, and JD degrees from top US and international universities including Princeton, Harvard, and Cornell. CaaMTech’s combined experience connects multiple industries, including branded and generic pharmaceutical companies, natural product innovation, Silicon Valley startups, intellectual property law, consumer product development, manufacturing, and distribution.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in CaaMTech?
CaaMTech has 2 investors on record on gritt.io, including 2 early-stage backers.
When did CaaMTech last raise funding?
The most recent investment in CaaMTech recorded on gritt.io was in January 2021.
When was CaaMTech founded?
CaaMTech was founded in 2019.
What industry is CaaMTech in?
CaaMTech operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is CaaMTech based?
CaaMTech is headquartered in Issaquah, United States.